Leveraging European infrastructures to access 1 million human genomes by 2022

Gary Saunders, Michael Baudis, Regina Becker, Sergi Beltran, Christophe Béroud, Ewan Birney, Cath Brooksbank, Søren Brunak, Marc Van den Bulcke, Rachel Drysdale, Salvador Capella-Gutierrez, Paul Flicek, Francesco Florindi, Peter Goodhand, Ivo Gut, Jaap Heringa, Petr Holub, Jef Hooyberghs, Nick Juty, Thomas M. KeaneJan O. Korbel, Ilkka Lappalainen, Brane Leskosek, Gert Matthijs, Michaela Th Mayrhofer, Andres Metspalu, Arcadi Navarro, Steven Newhouse, Tommi Nyrönen, Angela Page, Bengt Persson, Aarno Palotie, Helen Parkinson, Jordi Rambla, David Salgado, Erik Steinfelder, Morris A. Swertz, Alfonso Valencia, Susheel Varma, Niklas Blomberg, Serena Scollen*

*Corresponding author for this work

Research output: Contribution to JournalArticleAcademicpeer-review

7 Downloads (Pure)

Abstract

Human genomics is undergoing a step change from being a predominantly research-driven activity to one driven through health care as many countries in Europe now have nascent precision medicine programmes. To maximize the value of the genomic data generated, these data will need to be shared between institutions and across countries. In recognition of this challenge, 21 European countries recently signed a declaration to transnationally share data on at least 1 million human genomes by 2022. In this Roadmap, we identify the challenges of data sharing across borders and demonstrate that European research infrastructures are well-positioned to support the rapid implementation of widespread genomic data access.

Original languageEnglish
Pages (from-to)693-701
Number of pages9
JournalNature Reviews Genetics
Volume20
Issue number11
Early online date27 Aug 2019
DOIs
Publication statusPublished - Nov 2019

Funding

E.B. is a paid consultant to Oxford Nanopore, Glaxo-SmithKline and Dovetail Inc. S.Br. acknowledges funding from the Danish Agency for Science, Technology and Innovation (09–067306), Novo Nordisk Foundation (NNF14CC0001). P.F. is a member of the scientific advisory boards of Fabric Genomics, Inc., and Eagle Genomics, Ltd. The other authors declare no competing interests.

FundersFunder number
Danish Agency for Science and Higher Education09–067306
Novo Nordisk FondenNNF14CC0001

    Fingerprint

    Dive into the research topics of 'Leveraging European infrastructures to access 1 million human genomes by 2022'. Together they form a unique fingerprint.

    Cite this